Loading...
A classification prognostic score to predict OS in stage IV well-differentiated neuroendocrine tumors
No validated prognostic tool is available for predicting overall survival (OS) of patients with well-differentiated neuroendocrine tumors (WDNETs). This study, conducted in three independent cohorts of patients from five different European countries, aimed to develop and validate a classification pr...
Saved in:
Published in: | Endocr Relat Cancer |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Format: | Artigo |
Language: | Inglês |
Published: |
Bioscientifica Ltd
2018
|
Subjects: | |
Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5920017/ https://ncbi.nlm.nih.gov/pubmed/29559553 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1530/ERC-17-0489 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|